TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

COVID-19-drugs

World 5 years ago

Takeda-led COVID-19 plasma treatment unlikely to meet July goal of trial start

A group led by Takeda Pharmaceutical Co have completed test supplies of a blood plasma treatment for COVID-19, but pending regulator approval will likely prevent clinical trials from meeting a July start date.

World 5 years ago

Germany: Coronavirus vaccine unlikely to be widely available before mid-2021

Germany awarded three biotech companies grants to help them speed up the development of coronavirus vaccine candidates, but Research Minister Anja Karliczek said any vaccine was unlikely to be widely available before the middle of next year.

World 5 years ago

S. Korea's Green Cross seeks phase 2 trials of COVID-19 plasma drug

South Korea's Green Cross Corp has sought regulatory approval for Phase II trials of an experimental COVID-19 blood plasma treatment drug, the company said on Wednesday, sending its shares up nearly 10%.

World 5 years ago

Canada OKs remdesivir for use against coronavirus

Canada on Tuesday gave the green light for people with severe symptoms of COVID-19 to be treated with the anti-viral drug remdesivir.

World 5 years ago

Glenmark's favipiravir version shows promise in late-stage COVID-19 trial

India's Glenmark Pharmaceuticals Ltd said on Wednesday its version of anti-flu drug favipiravir showed promise in a late-stage study of 150 patients with mild to moderate coronavirus infection.

World 5 years ago

Japan approves dexamethasone as coronavirus treatment

Japan's health ministry has approved dexamethasone, a cheap and widely used steroid, as a second treatment of COVID-19 after a trial in Britain showed the drug reduced death rates in hospitalized patients.

World 5 years ago

South Korea approves human trials of Celltrion's COVID-19 antibody drug

South Korea on Friday approved an early stage clinical trial of Celltrion Inc's experimental COVID-19 treatment drug, making it the country's first such antibody drug to be tested on humans.

World 5 years ago

Hydroxychloroquine ineffective against mild COVID-19, US study shows

The anti-malaria drug touted by US President Donald Trump as a COVID-19 treatment was ineffective for patients with a mild version of the disease in a study conducted by researchers at the University of Minnesota.

World 5 years ago

One in three South Korean COVID-19 patients improve with remdesivir

One in three South Korean patients seriously ill with COVID-19 showed an improvement in their condition after being given Gilead Sciences Inc's antiviral remdesivir, health authorities said.

World 5 years ago

EU scrambles to buy intensive care drugs to tackle COVID shortages

The European Union is seeking firms to supply 24 intensive care drugs, an EU official told Reuters, as it strives to tackle shortages of medicines for COVID-19 patients amid fears of a second wave of infections and strong global demand.

TheJakartaPost

Popular Reads

Top Results

Popular Reads

Top Results

LOG IN

COVID-19-drugs

Takeda-led COVID-19 plasma treatment unlikely to meet July goal of trial start

Germany: Coronavirus vaccine unlikely to be widely available before mid-2021

S. Korea's Green Cross seeks phase 2 trials of COVID-19 plasma drug

Canada OKs remdesivir for use against coronavirus

Glenmark's favipiravir version shows promise in late-stage COVID-19 trial

Japan approves dexamethasone as coronavirus treatment

South Korea approves human trials of Celltrion's COVID-19 antibody drug

Hydroxychloroquine ineffective against mild COVID-19, US study shows

One in three South Korean COVID-19 patients improve with remdesivir

EU scrambles to buy intensive care drugs to tackle COVID shortages

follow our Social media